In 2025, Church & Dwight ( NYSE: CHD) expects reported sales growth of approximately of 2.5% to 3.5% and volume-driven ...

Bristol-Myers Squibb gets rated a hold, as I see future value in its clinical portfolio and pipeline, particularly ...

Google's near-term potential looks bright. Click here to read more on how AI can help improve the outlook for GOOGL stock.

Despite risks like geopolitical tensions and high capital expenses, TSMC's long-term vision and market leadership make it a ...

We like G Mining Ventures because the mgmt. team is experienced mine builders with access to capital, a rarity among junior ...

We admit to being miffed by Enovix's continued volatility. So why do we say we expect big things in the future? Click here to ...

Uniti Group’s precarious financial health results in a Hold rating. Find out why UNIT stock’s merger potential is outweighed ...

Logitech’s underlying growth momentum was great in Q3, driven by good product launches in gaming. Read why I downgraded my ...

The Western US solar fleet is amid rapid growth, with the region being home to four of the top five markets in planned ...

Fresenius Medical Care has seen 18.5% growth, with strong prospects. Learn why FMS stock’s fair value of $34/share makes it a ...

Fed kept its key interest rate on hold in a range between 4.25-4.5%, following three consecutive cuts. TD Asset Management's ...

Rilparencel is ProKidney’s main candidate. It is intended as a therapy that stabilizes kidneys, making it potentially useful ...